Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kampo RAKKUL granules is an over-the-counter (OTC) traditional Japanese Kampo medicine developed and marketed by Nippon Zoki Pharmaceutical. It is a full-prescription formulation of Goshajinkigan (also known as Niu-Che-Sen-Qi-Wan), a traditional herbal mixture composed of ten crude drugs: Rehmannia Root, Achyranthis Root, Cornus Fruit, Dioscorea Rhizome, Plantago Seed, Alisma Rhizome, Poria Sclerotium, Moutan Bark, Cinnamon Bark, and Processed Aconite Root. Kampo RAKKUL granules are indicated for the relief of lower back pain, leg pain, numbness, and other symptoms associated with lumbar nerve circulation problems, particularly in individuals with poor physical strength who easily fatigue and feel cold in their extremities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kampo RAKKUL granules.